Ryan Stansfield

1.1k total citations
11 papers, 355 citations indexed

About

Ryan Stansfield is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Ryan Stansfield has authored 11 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 1 paper in Infectious Diseases and 1 paper in Organic Chemistry. Recurrent topics in Ryan Stansfield's work include Histone Deacetylase Inhibitors Research (5 papers), Epigenetics and DNA Methylation (4 papers) and Genomics and Chromatin Dynamics (2 papers). Ryan Stansfield is often cited by papers focused on Histone Deacetylase Inhibitors Research (5 papers), Epigenetics and DNA Methylation (4 papers) and Genomics and Chromatin Dynamics (2 papers). Ryan Stansfield collaborates with scholars based in United States, Switzerland and Italy. Ryan Stansfield's co-authors include James M. Veal, Lihong Shi, Jeffrey A. Stafford, David J. Hosfield, Chon Lai, Shawn M. O’Connell, Jiangchun Xu, Zhe Nie, Toufike Kanouni and Young K. Chen and has published in prestigious journals such as Blood, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Ryan Stansfield

11 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryan Stansfield United States 8 281 60 53 26 18 11 355
Katherine S. England United Kingdom 6 315 1.1× 52 0.9× 36 0.7× 32 1.2× 21 1.2× 9 400
Isao Yasumatsu Japan 9 206 0.7× 60 1.0× 38 0.7× 37 1.4× 12 0.7× 17 271
Gillian M. Lamont United Kingdom 8 156 0.6× 75 1.3× 58 1.1× 35 1.3× 16 0.9× 15 243
Michael Burkard United States 10 164 0.6× 59 1.0× 58 1.1× 17 0.7× 24 1.3× 19 268
Daniel P. Mould United Kingdom 8 388 1.4× 54 0.9× 51 1.0× 28 1.1× 7 0.4× 8 440
Kin‐Chun Luk United States 10 202 0.7× 125 2.1× 113 2.1× 30 1.2× 26 1.4× 15 342
Masato Yabuki Japan 10 225 0.8× 56 0.9× 109 2.1× 26 1.0× 12 0.7× 15 294
Byung‐Chul Suh United States 8 157 0.6× 98 1.6× 26 0.5× 14 0.5× 9 0.5× 10 228
Susanna Stinson United States 3 175 0.6× 45 0.8× 114 2.2× 24 0.9× 12 0.7× 4 265
Elisabetta Di Bello Italy 10 232 0.8× 46 0.8× 74 1.4× 66 2.5× 33 1.8× 14 360

Countries citing papers authored by Ryan Stansfield

Since Specialization
Citations

This map shows the geographic impact of Ryan Stansfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Stansfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Stansfield more than expected).

Fields of papers citing papers by Ryan Stansfield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan Stansfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Stansfield. The network helps show where Ryan Stansfield may publish in the future.

Co-authorship network of co-authors of Ryan Stansfield

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan Stansfield. A scholar is included among the top collaborators of Ryan Stansfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan Stansfield. Ryan Stansfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Holleran, John P., Shweta Sharma, Angelina M. Santini, et al.. (2024). Abstract 2083: Discovery of ETX-19477, a novel and selective PARG inhibitor with high potency against tumors with underlying replication stress. Cancer Research. 84(6_Supplement). 2083–2083. 5 indexed citations
2.
Kanouni, Toufike, Christophe Severin, Natalie Yuen, et al.. (2020). Discovery of CC-90011: A Potent and Selective Reversible Inhibitor of Lysine Specific Demethylase 1 (LSD1). Journal of Medicinal Chemistry. 63(23). 14522–14529. 92 indexed citations
3.
Nie, Zhe, Lihong Shi, Chon Lai, et al.. (2018). Structure-based design and discovery of potent and selective lysine-specific demethylase 1 (LSD1) inhibitors. Bioorganic & Medicinal Chemistry Letters. 29(1). 103–106. 12 indexed citations
4.
Bennett, Malcolm J., Yiqin Wu, Amogh Boloor, et al.. (2018). Design, synthesis and biological evaluation of novel 4-phenylisoquinolinone BET bromodomain inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(10). 1811–1816. 7 indexed citations
5.
Nie, Zhe, Lihong Shi, Chon Lai, et al.. (2018). Structure-based design and discovery of potent and selective KDM5 inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(9). 1490–1494. 32 indexed citations
6.
Veal, James M., Miloš Lazić, Davide Povero, et al.. (2018). Discovery of Inhibitors of NLRP3 inflammasome assembly for the treatment of NASH and liver fibrosis. Journal of Hepatology. 68. S347–S348. 1 indexed citations
7.
Chen, Young K., Tiziana Bonaldi, Alessandro Cuomo, et al.. (2017). Design of KDM4 Inhibitors with Antiproliferative Effects in Cancer Models. ACS Medicinal Chemistry Letters. 8(8). 869–874. 51 indexed citations
8.
Haddach, Mustapha, Michael K. Schwaebe, Jerome Michaux, et al.. (2012). Discovery of CX-5461, the First Direct and Selective Inhibitor of RNA Polymerase I, for Cancer Therapeutics. ACS Medicinal Chemistry Letters. 3(7). 602–606. 114 indexed citations
9.
Martins, Leila R., Paulo Lúcio, Alice Melão, et al.. (2012). In Vitro and in Vivo Targeting of Chronic Lymphocytic Leukemia Using CX-4945, a Clinical-Stage CK2-Specific Inhibitor.. Blood. 120(21). 2897–2897. 3 indexed citations
10.
Pierre, Fabrice, Sean O’Brien, Mustapha Haddach, et al.. (2011). Novel potent pyrimido[4,5-c]quinoline inhibitors of protein kinase CK2: SAR and preliminary assessment of their analgesic and anti-viral properties. Bioorganic & Medicinal Chemistry Letters. 21(6). 1687–1691. 28 indexed citations
11.
Stansfield, Ryan, et al.. (1990). Urea metabolism in sheep given conventional feeds or nourished by intragastric infusion. Experimental Physiology. 75(2). 239–254. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katherine S. England Breakdown of academic impact, for papers by Isao Yasumatsu Breakdown of academic impact, for papers by Gillian M. Lamont Breakdown of academic impact, for papers by Michael Burkard Breakdown of academic impact, for papers by Daniel P. Mould Breakdown of academic impact, for papers by Kin‐Chun Luk Breakdown of academic impact, for papers by Masato Yabuki Breakdown of academic impact, for papers by Byung‐Chul Suh Breakdown of academic impact, for papers by Susanna Stinson Breakdown of academic impact, for papers by Elisabetta Di Bello
Rankless by CCL
2026